что касается наших продуктов, хочу

что касается наших продуктов, хочу сказать следующее
доступ на рынок обеспечивается через включение в списки Минздрава
республиканский лекарственный формуляр, амбулаторный список, список закупа
я постараюсь обновить информацию касательно формуляра
Минздрав имеет алгоритм, как основа для включения лекарств в списки, согласно этому алгоритму мы подготовили досье-обоснование и подписали сопроводительные письма, внесли на рассмотрение формулярной комиссии
заседание комиссии состоялось в конце декабря, приказ не подписан, но по предварительным данным наши продукты не включили в формуляр.
Наши следующие шаги - направить письма за подписью главных онкологов, чтобы Минздрав объяснил причину отказа и повторно рассмотреть на следующем заседании.
Параллельно будем работать с пациентами.

Results (English) 1:

with regard to our products, I would like to say the followingmarket access is provided through a listing of Ministry of healthnational drug formulary, ambulatory procurement list, listI will try to update the information on the formThe Ministry of health has an algorithm, as a basis for the inclusion of drugs on the list, according to this algorithm, we have prepared a dossier-support and signed cover letters, introduced the menu Boardmeeting of the Commission took place at the end of December, the order is not signed, but according to preliminary data, our products are not included in the form.Our next steps are to send a letter signed by top oncologists that Minzdrav explained the reason for the refusal and reconsidered at the next meeting.In parallel, we will work with patients.

Results (English) 2:

with regard to our products, I want to say
market access is provided through the inclusion in the lists of the Ministry of Health
Republican drug formularies, outpatient list, a list of purchase
I will try to update the information on the form
the Ministry of Health has an algorithm as a basis for inclusion in the list of drugs, according to this algorithm, we have prepared a dossier -obosnovanie and signed cover letters, introduced the formulary committee
meeting of the Commission held in the end of December, the order has not been signed, but according to preliminary data, our products are not included in the form.
Our next step - to send a letter signed by the principal oncologists to the Ministry of Health explained the reason for the refusal and reconsidered at the next meeting.
At the same time we will work with patients.

Results (English) 3:

With regard to our products, and I would like to say the following
market access is provided through the inclusion in the lists cardiologic
republican medication (a case, outpatient list, the list rental
I will try to update the information concerning a case
Brest is the algorithm, as a basis for inclusion in the lists medicines,According to the algorithm we have prepared a dossier of the rationale and signed letters of transmittal, have contributed to the consideration of the commission формулярнои
meeting of the Commission was held in the end of December, the order is not signed,But the preliminary data our products is not included in a case.
our the following steps - to send a letter of support signed by the oncologists,The psychiatrist explained the reason for the refusal, and re-consider at the next meeting.
in parallel will work with patients.